1-8 of 8
Shuangjiao Liu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

COVID-19 Vaccine Acceptance/Hesitancy and Influence on Infection in Patients with Multiple Myeloma: A National-Wide Multicenter Survey in China

Huiwen He, Ziping Li, Shuangjiao Liu, Wenming Chen, Wanling Sun, Baolai Hua, Yongzhe Li, Junling Zhuang
Journal: Blood
Blood (2023) 142 (Supplement 1): 6674.
https://doi.org/10.1182/blood-2023-174361
Published: 2023
Journal Articles

Efficacy and Prognostic Analysis of Percutaneous Vertebroplasty/Kyphoplasty in Patients with Newly Diagnosed Multiple Myeloma

Fujing Zhang, Shuzhong Liu, Xi Zhou, Shuangjiao Liu, Yong Liu, Junling Zhuang
Journal: Blood
Blood (2023) 142 (Supplement 1): 6700.
https://doi.org/10.1182/blood-2023-189263
Published: 2023
Journal Articles

The Value of PET/CT Combined with Next-Generation Flowcytometry in Minimal Residual Disease Detection and Prognostic Evaluation of Multiple Myeloma

Jianhua Du, Miao Chen, Li Huo, Wenjia Zhu, Huijuan Wang, Yun Leng, Shuangjiao Liu, Junling Zhuang
Journal: Blood
Blood (2022) 140 (Supplement 1): 7214.
https://doi.org/10.1182/blood-2022-165326
Published: 2022
Journal Articles

Myc Translocation Is a Notable Marker on the Development and Relapse of Extramedullary Disease in Multiple Myeloma

Yuhang Song, Jianhua Du, Fujing Zhang, Shuangjiao Liu, Junling Zhuang
Journal: Blood
Blood (2022) 140 (Supplement 1): 12513.
https://doi.org/10.1182/blood-2022-168148
Published: 2022
Journal Articles

Ixazomib Versus Lenalidomide or Ixazomib and Lenalidomide Combination As Maintenance Regimen for Patients with Multiple Myeloma: Interim Analysis of a Multi-Center Prospective Study in China

Zhe Zhuang, Ying Tian, Hong Yu, Lei Shi, Wei-wei Tian, Qinhua Liu, Dongmei Zou, Fei Dong, Yanping Ma, Ru Feng, Shuangjiao Liu, Hui Liu, Hongmei Jing, Wanling Sun, Liangming Ma, Li Bao, Rong Fu, Yin Wu, Chen Wenming, Junling Zhuang
Journal: Blood
Blood (2022) 140 (Supplement 1): 12637–12639.
https://doi.org/10.1182/blood-2022-169057
Published: 2022
Journal Articles

Myc Translocation Is an Adverse Factor Redefining High-Risk Multiple Myeloma

Xianghong Jin, Jianhua Du, Fujing Zhang, Hui Li, Shuangjiao Liu, Chen Yang, Miao Chen, Daobin Zhou, Junling Zhuang
Journal: Blood
Blood (2022) 140 (Supplement 1): 12575.
https://doi.org/10.1182/blood-2022-169332
Published: 2022
Journal Articles

Lenalidomide Versus Thalidomide or Bortezomib As Maintenance Regimens for Non-Transplant Patients with Multiple Myeloma: Multi-Center Real World Experience in China

Zhe Zhuang, Lei Shi, Ying Tian, Dongmei Zou, Ru Feng, Fei Dong, Yanping Ma, Hong Yu, Wei-wei Tian, Shuangjiao Liu, Liangming Ma, Rong Fu, Hongmei Jing, Hui Liu, Wanling Sun, Chen Wenming, Yin Wu, Li Bao, Junling Zhuang
Journal: Blood
Blood (2021) 138 (Supplement 1): 4728.
https://doi.org/10.1182/blood-2021-149502
Published: 2021
Journal Articles

Ixazomib Versus Lenalidomide or Ixazomib and Lenalidomide Combination As Maintenance Regimens for Patients with Multiple Myeloma: Interim Analysis of a Multi-Center Prospective Study in China

Zhe Zhuang, Ying Tian, Wei-wei Tian, Hong Yu, Dongmei Zou, Qinhua Liu, Lei Shi, Fei Dong, Yanping Ma, Ru Feng, Shuangjiao Liu, Hui Liu, Hongmei Jing, Li Bao, Wanling Sun, Rong Fu, Liangming Ma, Chen Wenming, Yin Wu, Junling Zhuang
Journal: Blood
Blood (2021) 138 (Supplement 1): 4766.
https://doi.org/10.1182/blood-2021-152542
Published: 2021